Latest News
Here you can find all the latest news from the MRC CTU at UCL.
'25 at 25': Transforming prostate cancer treatment through the STAMPEDE clinical trial
As part of our 25th anniversary celebrations, we look at the many achievements of the STAMPEDE clinical trial, which has tested 10 different treatments and changed the standard-of-care for prostate cancer four times in less than 20 years.
People who have had post-operative radiotherapy for prostate cancer may not also need hormone therapy
Final results from the RADICALS-HD clinical trial found no evidence that the addition of hormone therapy improved how long people lived without their cancer spreading, among patients whose doctors considered them suitable for short-term, long-term or no hormone therapy.
Spotlight on our research at ESMO Congress 2024
We will present our latest prostate cancer research from the PATCH, STAMPEDE and STAMPEDE2 trials at the 2024 ESMO Congress.
'25 at 25': Training and capacity strengthening
As part of our '25 at 25' series, we celebrate the Unit’s training and capacity strengthening efforts over the past two decades.
'25 at 25': OCTOPUS – speeding up new treatments for progressive MS
As part of our ’25 at 25’ series, we explore how the OCTOPUS trial in progressive multiple sclerosis (MS) aims to speed up the delivery of new treatments, bringing hope to the MS community.